Ethnopharmacological relevance Stroke is one of the leading causes of death and disability.
The only FDA-approved therapy for treating stroke is tissue plasminogen activator (tPA) …

Neuroprotective and neurorestorative therapy represent two major drug intervention
strategies for ischemic stroke. Multiple factors such as excitotoxicity, inflammation …

There is a growing interest in using natural medicines to treat stroke as the leading cause of
disability worldwide. Especially plant-derived natural medicines have multiple beneficial …

Background Ischemic stroke (IS) is a leading cause of death and severe long-term disability
worldwide. Over the past few decades, considerable progress has been made in anti …

Ischemic stroke is common in the elderly, and is one of the main causes of long-term
disability worldwide. After ischemic stroke, spontaneous recovery and functional …

Cerebral stroke is the second most leading cause of mortality and morbidity accompanied by
loss of blood supply to the particular area of brain. Increased level of reactive oxygen …

Cerebral ischemic stroke is a disease with high prevalence and incidence. Its management
focuses on rapid reperfusion with intravenous thrombolysis and endovascular …

Stroke is one of the leading causes of death and disability in adults worldwide, resulting in
huge social and financial burdens. Extracts from herbs, especially those used in Chinese …

Herbal medicines, mainly of plant source, are invaluable source for the discovery of new
therapeutic agents for all sorts of human ailments. The complex pathogenesis of stroke and …

Background: Chinese herbal medicine (CHM) has been used to treat stroke for thousands of
years. The objective of the study is to assess the current evidence for bioactive components …